“…Intravenous administration of the LPS from E. coli has been widely used as a model of sepsis in several animal species, including monkeys (Imaeda et al, 2002), pigs (Tadros et al, 2000), mice (Arribas et al, 2009;Lyu et al, 2015), rats (Wafa et al, 2015;Li et al, 2016) and rabbits (Gonzalo et al, 2010(Gonzalo et al, , 2015. LPS has been reported to evoke an inflammatory response (Lyu et al, 2015) and decrease the blood flow to the intestine, resulting in ischemic damage in the intestinal mucosa and increased epithelial barrier permeability (Tadros et al, 2000;Wafa et al, 2015;Li et al, 2016).…”